DiaMedica Therapeutics (DMAC) Assets Average (2019 - 2026)

DiaMedica Therapeutics has reported Assets Average for 8 years, with the latest figure at $57.2 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 34.37% year-over-year to $57.2 million; the trailing twelve-month figure through Mar 2026 stood at $57.2 million (up 34.37% YoY), and the FY2025 full-year result was $53.9 million, up 7.17% from the prior year.
• Assets Average for Q1 2026 stood at $57.2 million, down from $59.2 million in the prior quarter.
• The five-year high for Assets Average was $60.1 million in Q3 2023, with the low at $32.3 million in Q1 2023.
• Historically, Assets Average has averaged $47.1 million across 5 years, with a median of $46.1 million in 2023.
• Annual changes were most pronounced in 2022 — Assets Average jumped 76.61% — and 2025, when it tumbled 33.71%.
• DiaMedica Therapeutics' Assets Average stood at $35.7 million in 2022, then surged by 57.2% to $56.1 million in 2023, then retreated by 11.96% to $49.4 million in 2024, then rose by 19.77% to $59.2 million in 2025, then slipped by 3.35% to $57.2 million in 2026.
• The last three Assets Average figures came in at $57.2 million (Q1 2026), $59.2 million (Q4 2025), and $44.3 million (Q3 2025), per Business Quant data.